Babylon Holdings Limited (NYSE:BBLN – Get Rating) was the recipient of a large growth in short interest in the month of November. As of November 30th, there was short interest totalling 3,000,000 shares, a growth of 47.1% from the November 15th total of 2,040,000 shares. Based on an average trading volume of 679,900 shares, the short-interest ratio is currently 4.4 days. Approximately 1.0% of the shares of the company are sold short.

Institutional Investors Weigh In On Babylon

Several institutional investors have recently modified their holdings of BBLN. BNP Paribas Arbitrage SNC purchased a new stake in shares of Babylon during the 3rd quarter worth approximately $49,000. American International Group Inc. purchased a new stake in shares of Babylon during the 2nd quarter worth approximately $50,000. JPMorgan Chase & Co. boosted its stake in shares of Babylon by 886.5% during the 2nd quarter. JPMorgan Chase & Co. now owns 58,221 shares of the company's stock worth $57,000 after acquiring an additional 52,319 shares in the last quarter. Raymond James & Associates boosted its stake in shares of Babylon by 64.4% during the 3rd quarter. Raymond James & Associates now owns 125,033 shares of the company's stock worth $59,000 after acquiring an additional 49,000 shares in the last quarter. Finally, Millennium Management LLC boosted its stake in shares of Babylon by 312.1% during the 2nd quarter. Millennium Management LLC now owns 60,986 shares of the company's stock worth $60,000 after acquiring an additional 46,186 shares in the last quarter.

Babylon Stock Performance

NYSE BBLN opened at $0.44 on Wednesday. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 3.30. The business's 50 day moving average is $0.50 and its two-hundred day moving average is $0.75. Babylon has a 12-month low of $0.37 and a 12-month high of $7.16.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. Canaccord Genuity Group dropped their price target on Babylon from $4.00 to $2.00 and set a "buy" rating on the stock in a research report on Friday, November 11th. Canaccord Genuity Group dropped their price target on Babylon from $4.00 to $2.00 and set a "buy" rating on the stock in a research report on Friday, November 11th. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $4.57.

About Babylon

(Get Rating)

Babylon Holdings Limited operates as a digital healthcare company. It offers end-to-end care solution that facilities through its digital health suite, virtual care, in-person medical care, and post-care offerings. The company also provides Babylon Cloud services. It operates in the United Kingdom, the United States, the Asia Pacific, Canada, and internationally.

Featured Stories

• Get a free copy of the StockNews.com research report on Babylon (BBLN)
• Harpoon Therapeutics Remains Volatile After Promising News
• We Are the Champions: 3 Dividend Growers Wall Street Loves
• Will Nordstrom Stock be the Grinch This Year?
• What is Market Structure in Trading?
• Institutional Selling Is No Headwind For Nike

Receive News & Ratings for Babylon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Babylon and related companies with MarketBeat.com's FREE daily email newsletter.